Parallabs is a newly formed International corporation providing value added, technology driven bio-instruments to the Life Science research market.
From its headquarters in Boston USA Parallabs will manufacture and market its own products to the US and Asian markets. A European subsidiary with sales offices in England and Germany will market Parallabs own products and complementary products from niche manufacturers.
In May 2005 Parallabs inc acquired the assets and rights to manufacture the ‘Parallab 350’ an integrated processing and automation solution that greatly reduces the cycle time and reagents required for cycle sequencing, PCR,SNP, Genotyping and diagnostic reactions.